Back to funds

Bellevue Group AG

Updated 6 days ago

Managed by Bellevue Group Ag • Latest filing Q3 2026

Portfolio value
$4.8B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$5.3B
Q1 2026$4.2B
Q2 2026$4.8B
Q3 2026$4.8B

Top holdings

173 positions as of Q3 2026

View filing
A

AMGEN INC

Value
$350.5M
Shares
831.6K
% Port
7.27%
G

GILEAD SCIENCES INC

Value
$312M
Shares
2.09M
% Port
6.47%
V

VERTEX PHARMACEUTICALS INC

Value
$291.4M
Shares
557.4K
% Port
6.05%
A

ARGENX SE

Value
$277.9M
Shares
289.9K
% Port
5.77%
R

REGENERON PHARMACEUTICALS

Value
$211.9M
Shares
279.4K
% Port
4.40%
R

REVOLUTION MEDICINES INC

Value
$201.4M
Shares
981.0K
% Port
4.18%
I

INSMED INC

Value
$167.4M
Shares
1.47M
% Port
3.47%
V

VIRIDIAN THERAPEUTICS INC

Value
$146.3M
Shares
7.11M
% Port
3.04%
O

ORUKA THERAPEUTICS INC

Value
$136.3M
Shares
1.64M
% Port
2.83%
S

SCHOLAR ROCK HLDG CORP

Value
$134.7M
Shares
2.79M
% Port
2.79%
B

BIOGEN INC

Value
$134.4M
Shares
595.0K
% Port
2.79%
P

VAXCYTE INC

Value
$132M
Shares
2.32M
% Port
2.74%
R

RELAY THERAPEUTICS INC

Value
$111.6M
Shares
6.18M
% Port
2.32%
A

ABBOTT LABORATORIES

Value
$103.6M
Shares
1.05M
% Port
2.15%
I

INTUITIVE SURGICAL INC

Value
$100.8M
Shares
248.0K
% Port
2.09%
U

UNITED THERAPEUTICS CORP DEL

Value
$98.8M
Shares
182.3K
% Port
2.05%
M

MEDTRONIC PLC

Value
$90M
Shares
1.04M
% Port
1.87%
B

BRIDGEBIO PHARMA INC

Value
$77M
Shares
1.17M
% Port
1.60%
I

IMMUNOCORE HLDGS PLC

Value
$68.6M
Shares
2.26M
% Port
1.42%
E

ENLIVEN THERAPEUTICS INC

Value
$67.3M
Shares
1.47M
% Port
1.40%

Explore